Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Hodgkin lymphoma clinical trial record is displayed with its treatment plan, eligibility criteria, study locations, outcome measures, and record history, replacing an access-denied screen.
    Difference
    51%
    Check dated 2026-11-09T00:20:25.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-11-02T00:11:03.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A notice about NIH terminology changes and related updates appears above the ClinicalTrials.gov 403 error page.
    Difference
    1%
    Check dated 2026-10-26T00:18:38.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer's site revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T00:16:47.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T00:37:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the full study content with a minimal header/footer; this indicates the page is inaccessible, limiting visibility into the trial information and attachments.
    Difference
    18%
    Check dated 2026-09-20T22:57:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.